alexa
Reach Us +44-1202-068036
Aims and Scope - Clinical Pharmacology and Biopharmaceutics
ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Aims and Scope

 » Clinical Pharmacology & Biopharmaceutics a broad-based journal was founded on two key tenets: To publish the most exciting researches with respect to the subjects of Pharmacology & Biopharmaceutics. Secondly, to provide a rapid turn-around time possible for reviewing and publishing, and to disseminate the articles freely for research, teaching and reference purposes.

 »

In today's wired world information is available at the click of the button, curtsey the Internet. Clinical Pharmacology & Biopharmaceutics gives a world wide audience larger than that of any subscription-based journal, no matter how prestigious or popular, and probably increases the visibility and impact of published work. Clinical Pharmacology & Biopharmaceutics gives barrier-free access to the literature for research. It increases convenience, reach, and retrieval power. Free online literature is available for software that facilitates full-text searching, indexing, mining, summarizing, translating, querying, linking, recommending, alerting, "mash-ups" and other forms of processing and analysis. Clinical Pharmacology & Biopharmaceutics puts rich and poor on an equal footing for these key resources and eliminates the need for permissions to reproduce and distribute content.

 »

Clinical Pharmacology & Biopharmaceutics is ardent to Open Access. We strongly believe that removing barriers to research published online will greatly aid to the progress in scientific and technical disciplines.

 »

All published articles will be assigned DOI provided by CrossRef. Journal of Clinical Pharmacology & Biopharmaceutics will keep upto date with latest advances in the field and papers published in Journal of Clinical Pharmacology & Biopharmaceutics will reach the readers directly by email for free of cost.

 »

Distributed widely through the Internet.

 »

Archived online in the transactions of the Journal, which provides the international scientific community with immediate and permanent access to individual papers.

 »

Journal of Clinical Pharmacology & Biopharmaceutics accepts online letters to the editors, brief comments that contributes to the previously published articles or other relevant findings in Journal field.

 »

Open Access is a publication model, that enables the dissemination of research articles to the global community without restriction usually through the internet. Thus, all articles published under Open Access can be accessed by anyone with internet connection. Journal of Clinical Pharmacology & Biopharmaceutics strongly supports the Open Access initiative. Abstracts and full texts (HTML, PDF and XML format) of all articles published by Journal of Clinical Pharmacology & Biopharmaceutics are freely accessible to everyone immediately after publication.

 »

All works published by the Journal are under the terms of the Creative Commons Attribution License. This permits anyone to copy, distribute, transmit and adapt the work provided the original work and source is appropriately cited. Journal of Clinical Pharmacology & Biopharmaceutics supports the Bethesda Statement on Open Access Publishing.

Definition of Open Access Publication

 »

An Open Access Publication is one that meets the following two conditions:
 
  • The author(s) and copyright holder(s) grant(s) to all users a free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, transmit and display the work publicly and to make and distribute derivative works, in any digital medium for any responsible purpose, subject to proper attribution of authorship, as well as the right to make small numbers of printed copies for their personal use.
  •  

  • A complete version of the work and all supplemental materials, including a copy of the permission as stated above, in a suitable standard electronic format is deposited immediately upon initial publication in at least one online repository that is supported by an academic institution, scholarly society, government agency, or other well-established organization that seeks to enable Open Access, unrestricted distribution, interoperability, and long-term archiving (for the biomedical sciences, PubMed Central is such a repository).
 » As a member of Publisher International linking Association, PILA, Journal of Clinical Pharmacology & Biopharmaceutics follows the Creative Commons Attribution License and Scholars Open Access publishing policies.

Note:

 »

Community standards, rather than copyright law, will continue to provide the mechanism for enforcement of proper attribution and responsible use of the published work, as they do now.
Leave Your Message 24x7
Top